Bioorganic and Medicinal Chemistry Letters p. 4285 - 4288 (2003)
Update date:2022-08-04
Topics:
Perkins, James J.
Duong
Fernandez-Metzler, Carmen
Hartman, George D.
Kimmel, Donald B.
Leu, Chih-Tai
Lynch, Joseph J.
Prueksaritanont, Thomayant
Rodan, Gideon A.
Rodan, Sevgi B.
Duggan, Mark E.
Meissner, Robert S.
Antagonists of the integrin receptor αvβ3 are expected to have utility in the treatment of osteoporosis through inhibition of bone resorption. A series of potent, chain-shortened, pyrrolidinone-containing αvβ3 receptor antagonists is described. Two sets of diasteromeric pairs of high-affinity antagonists demonstrated marked differences in log P values, which translated into differing dog pharmacokinetic properties. One member of this set was demonstrated to be effective in reducing bone resorption in rats.
View MoreAllyChem Co., Ltd., Dalian, China(BBChem)
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
Contact:+49-9398-993127
Address:Untertorstr. 27
Hunan Haili Chemical Industry Co.,Ltd.
Contact:+86-731-85521860
Address:No.251, 2nd Section, Furong Road, Changsha,Hunan,China
Zouping Fuhai Technology Development Co., Ltd.
Contact:+0532-86934525 18660293207
Address:jiuhu town industrial park Zouping County,bingzhou Provincejiuhu town industrial park
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Doi:10.1021/ja01860a014
(1940)Doi:10.1016/S0040-4039(99)00577-8
(1999)Doi:10.1016/S0968-0896(02)00606-5
(2003)Doi:10.1039/j39690001346
(1969)Doi:10.1016/S0040-4020(99)00307-5
(1999)Doi:10.1016/S0031-9422(00)91376-1
(1974)